The Holidays are a time to give and receive. We want to give our heartfelt thanks to all of those who have given us their trust and support.
The generous funding from our partners and donors has permitted us to initiate, develop and accelerate breakthrough treatments through the world’s best clinical research projects. Our work has resulted in five portfolio projects and two pipeline projects, all with the potential to cure ovarian cancer.
We would never have reached these important milestones in 2017 without the loyal support from our donors, A. P. Møller Fonden, Det Obelske Familiefond, Jascha Fonden, Otto og Birthe Bangsdals Fond, Ole Kirk’s Fond, Orient Fonden, NTI Fonden and many more.
We also want to thank our pro-bono partners, strategic advisors, academic partners, clinical network and NGO partners for their ongoing support and commitment. Without your support and encouragement, our success wouldn’t have been possible.
Thank you for endorsing our mission to cure ovarian cancer – together.
We look forward to working with you in 2018!